Skip to main content

Table 1 Criteria considered in the pilot framework

From: Implementing reflective multicriteria decision analysis (MCDA) to assess orphan drugs value in the Catalan Health Service (CatSalut)

Criteria

Type of criteria

Source

Disease severity

Quantitative

Previous study [7]

Size of affected population

Quantitative

Previous study [7]

Unmet needs

Quantitative

Previous study [7]

Comparative effectiveness

Quantitative

Previous study [7]

Comparative safety/tolerability

Quantitative

Previous study [7]

Comparative patients perceived health (PRO)

Quantitative

Previous study [7]

Type of preventive benefit

Quantitative

Previous study [7]

Type of therapeutic benefit

Quantitative

Previous study [7]

Cost of orphan drug

Quantitative

Previous study [7]

Other medical costs

Quantitative

Previous study [7]

Non-medical costs

Quantitative

Previous study [7]

Quality of evidence

Quantitative

Previous study [7]

Expert consensus / clinical practice guidelines

Quantitative

Previous study [7]

Population priorities and access

Qualitative

Previous study [7]

Common goal and specific interests

Qualitative

Previous study [7]

Opportunity costs and affordability

Qualitative

Previous study [7]

System capacity and appropriate use of intervention

Qualitative

Previous study [7]

  1. PRO Patient Reported Outcomes